Inova Health Care Services
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Inova Health Care Services sits in the top decile of US sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count).
Inova Health Care Services: 75 sponsored US clinical trials, 22 recruiting.
Inova Health Care Services sponsors 75 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 32 completed. 10 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 3 trials.
Top-decile sponsor footprint
Inova Health Care Services ranks in the top decile of sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
32 of 48 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
75 total, page 1 of 2
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
NCT07485322
Volume Reduction for Open Fracture Irrigation
NCT07437339
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture
NCT07335224
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
NCT06939751
Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery
NCT07185425
Early Screening and Treatment of Heart Complication in Sickle Cell Disease
NCT07023666
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
NCT05710315
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
NCT06789757
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
NCT06931561
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
NCT06532890
Activity Coaching During Pelvic Radiation Therapy
NCT06746428
The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer
NCT05422690
Comparison of Two Salpingectomy Techniques for Sterilization at the Time of Cesarean Delivery
NCT06273683
Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes
NCT06273891
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy
NCT06106360
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
NCT06007846
Prevention of Postpartum Hemorrhage With Tranexamic Acid
NCT05370820
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure at Inova
NCT05433220
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm
NCT06675448
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
NCT04419480
NSAIDs vs. Coxibs in the Presence of Aspirin
NCT03699293
Inova Cardiogenic Shock Registry (INOVA SHOCK)
NCT03378739
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
NCT06023199
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
NCT07250763
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
NCT04282850
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
NCT05652218
Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery
NCT07167199
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
NCT06168825
Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
NCT05992623
Intrapartum Glycemic Control in GDMA2
NCT05647798
The Purpose of This Study is to Determine the Frequency of Colorectal Cancer in Male and Female Endurance Athletes Between the Ages of 35 and 50
NCT05419531
Buen Provecho!: A Virtual Family-Based Intervention to Promote Health
NCT05419557
Assessment of Cancer Related Brain Fog Using the Test of Strategic Learning
NCT05519774
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
NCT05338060
Distal Transradial Access for Percutaneous Coronary Intervention
NCT04801901
Healing Touch After Cesarean
NCT05053360
Biology Guided Therapy for Breast Cancer for ER Positive
NCT04965688
Effects of Aromatherapy on Nausea Levels
NCT04882501
TRANSFORM-HF Ancillary Mechanistic Study
NCT04702958
Characteristics of COVID-19 Infection Among PREGnant Women
NCT04398264
Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma
NCT04502472
Pharmacodynamics and Pharmacokinetics of Aspirin Inhalation Powder With Non-Enteric-Coated Chewable Aspirin
NCT04328883
Effectiveness of an Opioid Sparing Pain Regimen in Cardiac Surgery
NCT03679013
The Impact of Receptive Music Therapy in the ICU
NCT03931733
Blood Flow Restriction Following ACL Reconstruction
NCT03758755
CARESS: An Investigation of Effects of CARESS
NCT03758027
Standard Bupivacaine vs Liposomal Bupivacaine in Colorectal Patients
NCT03638635
Blood Glucose Monitoring in Electronic Health Records
NCT03542487
Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus
NCT03258281
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
NCT03326323
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 10 |
| Phase 3 | 1 |
| Phase 4 | 9 |
What is open in the Inova Health Care Services pipeline
22 recruiting of 75 indexed (29% open); 32 completed (43%).
Phase mix: 10 late (III/IV) vs 15 early (I/II) (balanced across stages).
Top condition: Heart Failure (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Inova Health Care Services: open-pipeline peers nationwide
Peers matched on 75 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Inova Health Care Services sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 75 trials (± recruiting share)
- C. R. Bard · 75 trials · 5% recruiting
- ECOG-ACRIN Cancer Research Group · 75 trials · 16% recruiting
- Hartford Hospital · 75 trials · 11% recruiting
- Ionis Pharmaceuticals · 76 trials · 12% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Children's Hospital Los Angeles · 29% recruiting · 119 trials
- Natural Immune Systems · 29% recruiting · 17 trials
- Ono Pharmaceutical Co. · 29% recruiting · 17 trials
- Queen's Medical Center · 29% recruiting · 17 trials
Related
What to do with this Inova Health Care Services page
75 registered trials is a research-attention snapshot, not an endorsement of Inova Health Care Services or any single study.
- 22 of Inova Health Care Services's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Inova Health Care Services studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Inova Health Care Services pipeline card: 75 registered trials from official public datasets.Report a data error.